Pro Medicus Limited (ASX: PME) has signed a A$53 million contract with BayCare, one of Florida’s leading healthcare systems. The 7-year deal will see BayCare replace its legacy PACS and…
Predictive Discovery Secures $69M Strategic Placement from Lundin Family and Zijin Mining
Predictive Discovery Limited (ASX: PDI) has locked in a major $69.2 million investment through a strategic private placement with the Lundin Family and Zijin Mining Group. This funding will accelerate…
Woolworths Announces Leadership Changes and Organisational Restructure
Woolworths Group (ASX: WOW) has unveiled key leadership changes and an organisational restructure aimed at enhancing customer impact and simplifying operations within its food division. Key Leadership Appointments Annette Karantoni…
Westpac Appoints Paul Fowler as Chief Executive, Business & Wealth
Westpac (ASX: WBC) has announced the appointment of Paul Fowler as Chief Executive, Business & Wealth, bringing over 20 years of experience in financial services, corporate finance, and wealth management….
Resolute Mining CEO Steps Down, Chris Eger Appointed as Successor
There’s a shake-up at Resolute Mining (ASX/LSE: RSG) as CEO and Managing Director Terry Holohan departs with immediate effect. The company is currently discussing the terms of a proposed settlement…
Paradigm Teams Up with Advanced Clinical for Pivotal Osteoarthritis Trial
Big news from Paradigm Biopharmaceuticals – they’ve officially chosen Advanced Clinical as their Clinical Research Organisation (CRO) for the upcoming Phase 3 clinical trial (PARA_OA_012). This is a major step…
Mach7 Announces $5M Share Buy-Back, Signaling Confidence in Future Growth
Mach7 Technologies (ASX: M7T) is backing itself with a $5 million on-market share buy-back, set to kick off on March 3, 2025, and run for up to 12 months. With…
Nanosonics Limited (ASX:NAN) H1 FY25 Trading Update
Strong Start to FY25 with Profit and Revenue GrowthNanosonics Limited (ASX:NAN), a global leader in infection prevention solutions, has released its preliminary unaudited results for H1 FY25, showcasing significant growth…
Adore Beauty Group Delivers Strong Growth in H1 FY25 Amid Strategy Refresh
Highlights CEO Commentary Sacha Laing, CEO of Adore Beauty, stated: “Our first-half results reflect the success of our strategy refresh, with disciplined execution driving both profit growth and margin expansion….
4DMedical Secures First Australian Commercial Contract with Qscan
4DMedical Limited (ASX:4DX), a leader in respiratory imaging technology, has announced a milestone agreement with Qscan Radiology Clinics. Following the success of a pilot program, this commercial contract marks the…